查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1387492

转染试剂与设备市场报告：2030 年趋势、预测与竞争分析

Transfection Reagent and Equipment Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

转染试剂和设备的趋势和预测

预计到 2030 年，全球转染试剂和设备市场将达到 19 亿美元，2024 年至 2030 年年复合成长率为 6.5%。该市场的主要驱动力是全球慢性疾病负担的增加、对合成基因的高需求以及转染技术的进步。全球转染试剂和设备市场的未来前景广阔，学术和研究机构以及製药和生物技术公司市场存在商机。

转染试剂和设备市场洞察

Lucintel 预测，随着主要企业推出许多产品以扩大其试剂产品组合的广度，预计试剂在预测期内将出现高速成长。

在这个市场中，由于疾病负担的增加以及试剂和设备在全球范围内的采用不断增加，製药和生物技术公司将继续成为最大的细分市场。

由于基因组学研究和开发投资的增加、蛋白质治疗药物需求的增加以及该地区领先公司的存在，北美在预测期内可能仍是最大的市场。

本报告回答了 11 个关键问题：

  • Q.1. 细分市场中最有前途和高成长的机会是什么？
  • Q.2.哪个细分市场将以更快的速度成长？为什么？
  • Q.3.您认为哪些地区未来会出现更快的成长？为什么？
  • Q.4. 影响市场动态的主要因素有哪些？市场的主要挑战和商业风险是什么？
  • Q.5. 这个市场的商业风险和竞争威胁是什么？
  • Q.6.这个市场有哪些新趋势？为什么？
  • Q.7.市场客户需求有何改变？
  • Q.8. 该市场有哪些新发展以及哪些公司处于领先地位？
  • Q.9.这个市场的主要企业有哪些？主要企业采取哪些策略配合措施来发展业务？
  • Q.10. 该市场上的竞争产品有哪些？由于材料或产品替代而导致市场占有率下降的威胁有多大？
  • Q.11.过去年度发生了哪些併购事件，对产业产生了哪些影响？

目录

第1章执行摘要

第2章全球转染试剂与设备市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第3章2018-2030年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球转染试剂和设备市场趋势（2018-2023）和预测（2024-2030）
  • 全球转染试剂和设备市场（按产品）
    • 试剂
    • 装置
  • 按方法分類的全球转染试剂和设备市场
    • 物理方法
    • 生化方法
    • 病毒法
  • 全球转染试剂和设备市场（按应用）
    • 蛋白质生产
    • 生化研究
    • 提供治疗方法
  • 以最终用途分類的全球转染试剂和设备市场
    • 学术/研究机构
    • 製药和生物技术公司
    • 其他的

第4章2018-2030年分地区市场趋势及预测分析

  • 全球转染试剂和设备市场（按地区）
  • 北美转染试剂及设备市场
  • 欧洲转染试剂及设备市场
  • 亚太转染试剂及设备市场
  • 其他地区转染试剂及设备市场

第5章竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第6章成长机会与策略分析

  • 成长机会分析
    • 全球转染试剂和设备市场成长机会（按产品）
    • 按方法分類的全球转染试剂和设备市场成长机会
    • 全球转染试剂和设备市场成长机会（按应用）
    • 按最终用途分類的全球转染试剂和设备市场的成长机会
    • 全球转染试剂和设备市场按地区成长机会
  • 全球转染试剂及设备市场新趋势
  • 战略分析
    • 新产品开发
    • 扩大全球转染试剂和设备市场的产能
    • 全球转染试剂和设备市场的合併、收购和合资
    • 认证和许可

第7章主要企业概况

  • PromoCell
  • OriGene Technologies
  • Thermo Fisher Scientific
  • Merck
  • Bio-Rad Laboratories
  • Lonza
  • Qiagen NV
  • Mirus Bio
  • Promega Corporation
  • F. Hoffmann-La Roche
简介目录

Transfection Reagent and Equipment Trends and Forecast

The future of the global transfection reagent and equipment market looks promising with opportunities in the academic & research institute and parmaceutical & biotechnology company markets. The global transfection reagent and equipment market is expected to reach an estimated $1.9 billion by 2030 with a CAGR of 6.5% from 2024 to 2030. The major drivers for this market are increasing burden of chronic diseases across the globe, high demand for synthetic genes, and technological advancements in transfection.

A more than 150-page report is developed to help in your business decisions.

Transfection Reagent and Equipment by Segment

The study includes a forecast for the global transfection reagent and equipment by product, method, application, end use, and region.

Transfection Reagent and Equipment Market by Product [Shipment Analysis by Value from 2018 to 2030]:

  • Reagents
  • Equipment

Transfection Reagent and Equipment Market by Method [Shipment Analysis by Value from 2018 to 2030]:

  • Physical Methods
  • Biochemical Methods
  • Viral Methods

Transfection Reagent and Equipment Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Protein Production
  • Biomedical Research
  • Therapeutic Delivery

Transfection Reagent and Equipment Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Academics & Research Institutes
  • Pharmaceutical & Biotechnology Companies
  • Others

Transfection Reagent and Equipment Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Transfection Reagent and Equipment Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies transfection reagent and equipment companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the transfection reagent and equipment companies profiled in this report include-

  • PromoCell
  • OriGene Technologies
  • Thermo Fisher Scientific
  • Merck
  • Bio-Rad Laboratories
  • Lonza
  • Qiagen N.V.
  • Mirus Bio
  • Promega Corporation
  • F. Hoffmann-La Roche

Transfection Reagent and Equipment Market Insights

Lucintel forecasts that reagents is expected to witness the higher growth over the forecast period due to huge number of launches by key players so as to broaden their reagents portfolio.

Within this market, pharmaceutical & biotechnology companies will remain the largest segment due to increasing burden of diseases and rising adoption of reagent and equipment worldwide.

North America will remain the largest segment over the forecast period due to rising investments in research and development in genomics, growing demand for protein therapeutics, and the existence of major players in the region.

Features of the Global Transfection Reagent and Equipment Market

Market Size Estimates: Transfection reagent and equipment market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Transfection reagent and equipment market size by various segments, such as by product, method, application, end use, and region in terms of value ($B).

Regional Analysis: Transfection reagent and equipment market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different products, methods, applications, end uses, and regions for the transfection reagent and equipment market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the transfection reagent and equipment market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the transfection reagent and equipment market size?

Answer: The global transfection reagent and equipment market is expected to reach an estimated $1.9 billion by 2030.

Q2. What is the growth forecast for transfection reagent and equipment market?

Answer: The global transfection reagent and equipment market is expected to grow with a CAGR of 6.5% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the transfection reagent and equipment market?

Answer: The major drivers for this market are increasing burden of chronic diseases across the globe, high demand for synthetic genes, and technological advancements in transfection.

Q4. What are the major segments for transfection reagent and equipment market?

Answer: The future of the transfection reagent and equipment market looks promising with opportunities in the academic & research institute and parmaceutical & biotechnology company markets.

Q5. Who are the key transfection reagent and equipment market companies?

Answer: Some of the key transfection reagent and equipment companies are as follows:

  • PromoCell
  • OriGene Technologies
  • Thermo Fisher Scientific
  • Merck
  • Bio-Rad Laboratories
  • Lonza
  • Qiagen N.V.
  • Mirus Bio
  • Promega Corporation
  • F. Hoffmann-La Roche

Q6. Which transfection reagent and equipment market segment will be the largest in future?

Answer: Lucintel forecasts that reagents is expected to witness the higher growth over the forecast period due to huge number of launches by key players so as to broaden their reagents portfolio.

Q7. In transfection reagent and equipment market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest segment over the forecast period due to rising investments in research and development in genomics, growing demand for protein therapeutics, and the existence of major players in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the transfection reagent and equipment market by product (reagents and equipment), method (physical methods, biochemical methods, and viral methods), application (protein production, biomedical research, and therapeutic delivery), end use (academics & research institutes, pharmaceutical & biotechnology companies, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Transfection Reagent and Equipment Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Transfection Reagent and Equipment Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Transfection Reagent and Equipment Market by Product
    • 3.3.1: Reagents
    • 3.3.2: Equipment
  • 3.4: Global Transfection Reagent and Equipment Market by Method
    • 3.4.1: Physical Methods
    • 3.4.2: Biochemical Methods
    • 3.4.3: Viral Methods
  • 3.5: Global Transfection Reagent and Equipment Market by Application
    • 3.5.1: Protein Production
    • 3.5.2: Biomedical Research
    • 3.5.3: Therapeutic Delivery
  • 3.6: Global Transfection Reagent and Equipment Market by End Use
    • 3.6.1: Academics & Research Institutes
    • 3.6.2: Pharmaceutical & Biotechnology Companies
    • 3.6.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Transfection Reagent and Equipment Market by Region
  • 4.2: North American Transfection Reagent and Equipment Market
    • 4.2.2: North American Transfection Reagent and Equipment Market by End Use: Academics & Research Institutes, Pharmaceutical & Biotechnology Companies, and Others
  • 4.3: European Transfection Reagent and Equipment Market
    • 4.3.1: European Transfection Reagent and Equipment Market by Product: Reagents and Equipment
    • 4.3.2: European Transfection Reagent and Equipment Market by End Use: Academics & Research Institutes, Pharmaceutical & Biotechnology Companies, and Others
  • 4.4: APAC Transfection Reagent and Equipment Market
    • 4.4.1: APAC Transfection Reagent and Equipment Market by Product: Reagents and Equipment
    • 4.4.2: APAC Transfection Reagent and Equipment Market by End Use: Academics & Research Institutes, Pharmaceutical & Biotechnology Companies, and Others
  • 4.5: ROW Transfection Reagent and Equipment Market
    • 4.5.1: ROW Transfection Reagent and Equipment Market by Product: Reagents and Equipment
    • 4.5.2: ROW Transfection Reagent and Equipment Market by End Use: Academics & Research Institutes, Pharmaceutical & Biotechnology Companies, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Transfection Reagent and Equipment Market by Product
    • 6.1.2: Growth Opportunities for the Global Transfection Reagent and Equipment Market by Method
    • 6.1.3: Growth Opportunities for the Global Transfection Reagent and Equipment Market by Application
    • 6.1.4: Growth Opportunities for the Global Transfection Reagent and Equipment Market by End Use
    • 6.1.5: Growth Opportunities for the Global Transfection Reagent and Equipment Market by Region
  • 6.2: Emerging Trends in the Global Transfection Reagent and Equipment Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Transfection Reagent and Equipment Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Transfection Reagent and Equipment Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: PromoCell
  • 7.2: OriGene Technologies
  • 7.3: Thermo Fisher Scientific
  • 7.4: Merck
  • 7.5: Bio-Rad Laboratories
  • 7.6: Lonza
  • 7.7: Qiagen N.V.
  • 7.8: Mirus Bio
  • 7.9: Promega Corporation
  • 7.10: F. Hoffmann-La Roche